Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

259 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Metabolic targets for cancer therapy.
Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Nat Rev Drug Discov. 2013 Nov;12(11):829-46. doi: 10.1038/nrd4145. Epub 2013 Oct 11. Nat Rev Drug Discov. 2013. PMID: 24113830 Review.
To die or not to die: that is the autophagic question.
Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Curr Mol Med. 2008 Mar;8(2):78-91. doi: 10.2174/156652408783769616. Curr Mol Med. 2008. PMID: 18336289 Review.
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death.
Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, Pinna G, Larochette N, Zamzami N, Modjtahedi N, Harel-Bellan A, Kroemer G. Tajeddine N, et al. Among authors: kepp o. Oncogene. 2008 Jul 10;27(30):4221-32. doi: 10.1038/onc.2008.63. Epub 2008 Mar 24. Oncogene. 2008. PMID: 18362892
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, Fimia GM, Kepp O, Piacentini M, Froehlich KU, van Endert P, Zitvogel L, Madeo F, Kroemer G. Panaretakis T, et al. Among authors: kepp o. Cell Death Differ. 2008 Sep;15(9):1499-509. doi: 10.1038/cdd.2008.67. Epub 2008 May 9. Cell Death Differ. 2008. PMID: 18464797
Targeting p53 to mitochondria for cancer therapy.
Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Cell Cycle. 2008 Jul 1;7(13):1949-55. doi: 10.4161/cc.7.13.6222. Cell Cycle. 2008. PMID: 18642442 Review.
Immunogenic cell death modalities and their impact on cancer treatment.
Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, Kroemer G. Kepp O, et al. Apoptosis. 2009 Apr;14(4):364-75. doi: 10.1007/s10495-008-0303-9. Apoptosis. 2009. PMID: 19145485 Review.
Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg5.
Rello-Varona S, Vitale I, Kepp O, Senovilla L, Jemaá M, Métivier D, Castedo M, Kroemer G. Rello-Varona S, et al. Among authors: kepp o. Cell Cycle. 2009 Apr 1;8(7):1030-5. doi: 10.4161/cc.8.7.7950. Epub 2009 Apr 27. Cell Cycle. 2009. PMID: 19270519
Nutlin kills cancer cells via mitochondrial p53.
Morselli E, Galluzzi L, Kepp O, Kroemer G. Morselli E, et al. Among authors: kepp o. Cell Cycle. 2009 Jun 1;8(11):1647-8. Cell Cycle. 2009. PMID: 19448434 No abstract available.
Mitochondrial gateways to cancer.
Galluzzi L, Morselli E, Kepp O, Vitale I, Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Mol Aspects Med. 2010 Feb;31(1):1-20. doi: 10.1016/j.mam.2009.08.002. Epub 2009 Aug 19. Mol Aspects Med. 2010. PMID: 19698742 Review.
Chemotherapy induces ATP release from tumor cells.
Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, Séror C, Métivier D, Perfettini JL, Zitvogel L, Kroemer G. Martins I, et al. Among authors: kepp o. Cell Cycle. 2009 Nov 15;8(22):3723-8. doi: 10.4161/cc.8.22.10026. Epub 2009 Nov 8. Cell Cycle. 2009. PMID: 19855167
259 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page